RegMed Forum “The multifaceted potential of CRISPR-Cas9 in medicine”
Venue
Auditorium Friedrichstraße
Friedrichstraße 180
Im Quartier 110
10117 bERLIN
Deutschland
Zeit
Program
Preliminary agenda
Moderator: Dimitrios Wagner, BCRT/BeCAT
16.15 Registration & Coffee
17.00-17.05 Jasmin Podufall (BPWT) - Welcome Address
17.05-17.15 Dimitrios Wagner (BCRT/BeCAT) - Evolution of the CRISPR-Cas9 technology
17.15-17.35 N.N. (University of Regensburg) - CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia (title tbc)
17.35-17.55 Leila Amini (BCRT/BeCAT) - CRISPR-based immune cell therapies (title tbc)
17.55-18.15 Andre Cohnen (Bayer AG) - Novel CRISPR enzymes from nature and lab (title tbc)
18.15-19.00 BREAK
19.00-19.20 Michael Kaminski (MDC/Charité) - CRISPR-based diagnostics (title tbc)
19.20-19.40 Simone Spuler (MDC/Charité) - CRISPR-based therapies for genetic muscle disorders (title tbc)
19.40-20.10 N.N.
20.10-20.20 Dimitrios Wagner & Jasmin Podufall - Closing remarks
20.20-21.15 Get together & Networking
Organisator*innen
BIH Center for Regenerative Medicine (BCRT) & Cluster Health Capital